Ekrem Unal: Navigating the Budget Impact of Next-Generation Hemophilia Therapies in Turkey
Ekrem Unal, Professor of Pediatric Hematology Oncology and Pediatric HSCT at Hasan Kalyoncu University, Medical Point Hospital, Gaziantep, Turkey, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
”We are moving from lifelong intravenous infusions to single-dose gene therapies and seamless subcutaneous agents in hemophilia care.
But as the therapeutic landscape shifts, how prepared are developing economies to absorb the heavy budget impact of these high-value innovations?
Our latest comprehensive review, now published in Clinical and Applied Thrombosis/Hemostasis (SCIE, Impact Factor: 3.2, Q2 in Hematology), analyzes the expanding real-world experience, access barriers, and future opportunities in regions like Türkiye and beyond.
Read our full paper to explore the delicate balance between medical breakthroughs and healthcare sustainability.”
Title: The Dilemma of Providing Advanced Hemophilia Treatments in Developing Countries – For Whom, by Whom and Where?
Authors: Kaan Kavaklı, Canan Albayrak, Bulent Antmen, Selin Aytac, Can Balkan, Zuhre Kaya, Alphan Kupesiz, Vahap Okan, Mehmet Sonmez, Fahri Sahin, Ekrem Unal, Bulent Zulfikar
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom
-
Sep 19, 2026, 01:38Jeff Sternlicht: A Heart Attack Should Not Be the Starting Line
-
Sep 19, 2026, 01:28Luis Oliverio Ambriz Garcia: Key Points From the ASH 2026 Guidelines on Iron Deficiency
-
Sep 19, 2026, 01:27Farjah Algahtani: A New Era in the Treatment of Transfusion-Dependent Thalassaemia
-
Sep 19, 2026, 01:24Aravind Palraj: 2025 EULAR Behçet’s Syndrome Update – 5 Practical Take-Home Points